Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 recruiting3 with results

Enrollment Performance

Analytics

N/A
8(100.0%)
8Total
N/A(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)